Resources

PFE – Market expectations are for PFE to see stable Uniform ROA at current levels, driven by competitive headwinds, pricing concerns, and recent developments

April 17, 2018

      • Pfizer Inc. (PFE:USA)currently trades below corporate averages relative to UAFRS-based (Uniform) Earnings, with a 15.4x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to remain at current 19%-20% levels through 2021, with these muted expectations being driven by competitive headwinds, pricing concerns, and recent developments
      • Specifically, markets are pricing in uncertainty surrounding the potential of PFE’s pipeline, made more important by the fact that the firm is aiming to divest its non-core assets. Additionally, the firm may face further LOE and competition-related headwinds going forward, making it increasingly difficult for them to drive material operational improvements, and may also face pricing pressures as a result of regulation

You don’t have access to the Valens Research Premium Application.

To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email client.relations@valens-research.com.

Please fill out the fields below so that our client relations team can contact you

Or contact our Client Relationship Team at 630-841-0683